50-198-2151

GCNT1 Rabbit anti-Human, Polyclonal, Bioss

Manufacturer: Bioss

Select a Size

Pack Size SKU Availability Price
Each of 1 50-198-2151-Each-of-1 In Stock ₹ 38,381.25

50-198-2151 - Each of 1

₹ 38,381.25

In Stock

Quantity

1

Base Price: ₹ 38,381.25

GST (18%): ₹ 6,908.625

Total Price: ₹ 45,289.875

Antigen

GCNT1

Classification

Polyclonal

Conjugate

Unconjugated

Gene

GCNT1

Gene Alias

5630400D21Rik; B130048E03; Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N--acetylglucosaminyltransferase; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase (Core 2 branching enzyme) (Core2-GlcNAc-transferase) (C2GNT); beta-1,6-N-acetylglucosaminyltransferase; C2 GlcNAcT; C2GNT; C2GNT1; C2GNT-L; core 2 beta1,6 N-acetylglucosaminyltransferase-I; core 2 beta-1,6-N-acetylglucosaminyltransferase I; core 2 branching enzyme; core 2 GnT; Core 2-branching enzyme; Core2-GlcNAc-transferase; G6NT; GCNT1; glucosaminyl (N-acetyl) transferase 1, core 2; glucosaminyl (N-acetyl) transferase 1, core 2 (beta-1,6-N-acetylglucosaminyltransferase); IGnT; NACGT2; NAGCT2

Host Species

Rabbit

Purification Method

Protein A

Regulatory Status

RUO

Gene ID (Entrez)

2650

Content And Storage

-20°C

Form

Liquid

Applications

Immunofluorescence, Immunohistochemistry (Paraffin), Western Blot

Concentration

1 μg/mL

Formulation

PBS with 1% BSA, 50% glycerol and 0.09% sodium azide; pH

Gene Accession No.

Q02742

Gene Symbols

GCNT1

Immunogen

KLH conjugated synthetic peptide derived from human GCNT1.

Quantity

100 μL

Primary or Secondary

Primary

Target Species

Human

Product Type

Antibody

Isotype

IgG

Related Products

Img

Abbomax Inc

50-220-4281

--

Img

Bioss

50-198-2897

--

Img

Bioss

50-198-2757

--

Img

Bioss

50-198-2759

--

Img

Bioss

50-198-2760

--

Img

Bioss

50-198-2847

--

Img

Bioss

50-198-2758

--

Img

Bioss

50-198-8659

--

Description

  • Glycosylation is one of the most universal but at the same time complex protein modifications
  • Modification with sugar moeties can be both co- translational and post- translational, occurring in the endoplasmatic reticulum and golgi
  • Three different forms of glycosylation can be distinguished: N-linked oligosaccharides, O-linked oligosaccharides and glycosyl- phosphatidylinositol (GPI-) anchors
  • Glycosylation results in thousands of distinct, bioactive glycoproteins resident throughout the cell that strongly determine protein-protein, carbohydrate-protein, membrane, and adhesion properties
  • Diseases associated with glycosylation defects include Congenital disorders of glycosylation, (CDG), also known as carbohydrate deficient glycoprotein syndromes, and diseases associated with advanced aging.